(Total Views: 498)
Posted On: 09/18/2020 11:19:36 AM
Post# of 148891
https://www.cytodyn.com/newsroom/press-releas...ts-phase-3
The PR states to the contrary. How can CYDY perform an interim analysis that may take a few weeks if they won't have access to the unblinded interim data? There is a serious gap here and I hope CYDY is right and we are the ones that don't understand the process. But based on the wording in the FDA link, it seems CYDY is seriously mistaken. This would be a terrible & embarrassing misstep! Even more so than the "filed" vs "requested opinion" fiasco.
The PR states to the contrary. How can CYDY perform an interim analysis that may take a few weeks if they won't have access to the unblinded interim data? There is a serious gap here and I hope CYDY is right and we are the ones that don't understand the process. But based on the wording in the FDA link, it seems CYDY is seriously mistaken. This would be a terrible & embarrassing misstep! Even more so than the "filed" vs "requested opinion" fiasco.
(2)
(0)Scroll down for more posts ▼
